Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · IEX Real-Time Price · USD
2.440
+0.410 (20.20%)
Apr 5, 2024, 3:59 PM EDT - Market closed
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $17.55 million as of July 26, 2024. Its market cap has increased by 9.67% in one year.
Market Cap
17.55M
Enterprise Value
7.96M
1-Year Change
9.67%
Ranking
Category
Stock Price
$2.44
Market Cap Chart
Since August 4, 2015, Indaptus Therapeutics's market cap has decreased from $60.70M to $17.55M, a decrease of -71.09%. That is a compound annual growth rate of -12.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 17.30M | 16.89% |
| Dec 29, 2023 | 14.80M | 23.33% |
| Dec 30, 2022 | 12.00M | -74.30% |
| Dec 31, 2021 | 46.70M | 243.38% |
| Dec 31, 2020 | 13.60M | -22.29% |
| Dec 31, 2019 | 17.50M | -91.10% |
| Dec 31, 2018 | 196.60M | 233.22% |
| Dec 29, 2017 | 59.00M | -9.65% |
| Dec 30, 2016 | 65.30M | 20.48% |
| Dec 31, 2015 | 54.20M | -10.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viracta Therapeutics | 19.07M |
| Lyra Therapeutics | 18.84M |
| Gain Therapeutics | 18.77M |
| Aptorum Group | 18.14M |
| Conduit Pharmaceuticals | 17.87M |
| PharmaCyte Biotech | 17.08M |
| Sensei Biotherapeutics | 17.02M |
| Aeterna Zentaris | 16.99M |